Background The gabapentinoid drugs gabapentin and pregabalin were originally
developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For …

Gabapentin and Pregabalin for Pain — Is Increased Prescribing a Cause for Concern? |
New England Journal of Medicine Skip to main content The New England Journal of …

Methods| Using the Clinical Practice Research Datalink (CPRD), a UK database of primary
care medical records from more than 15 million patients, 5 we identified all patients …

OBJECTIVES:(1) Describe the relevance of off-label use of gabapentin to managed care
pharmacy;(2) summarize recent FDA warnings and media reports related to off-label …

Background There is good evidence of selective outcome reporting in published reports of
randomized trials. Methods We examined reporting practices for trials of gabapentin funded …

Clinical Question Is gabapentin associated with pain relief in people with chronic
neuropathic pain? Bottom Line Oral gabapentin (1200-3600 mg/d for 4-12 weeks) for …

Gabapentin and pregabalin are structurally related compounds which are classified as
gammaaminobutyric acid (GABA) analogues or gabapentinoids (Figure 1). Gabapentin …

Gabapentin is widely used in the United States for a number of off-label indications, often as
an alternative to opioid therapy. Increasing evidence has emerged suggesting that …

Abstract Background February 2009: The authors are aware of unpublished trial data for
Gabapentin which could affect the results of this review. This information together with that …

Introduction Recent years have seen a dramatic escalation of off-label prescribing for
gabapentin and pregabalin (gabapentinoids) owing in part to generic versions of each being …